CLINICAL_TRIALS
trial_result
· 2026-03-30
Clinical Trial Update: The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula [Phase 2]
Summary
Phase 2 clinical trial evaluating Yiqilishui Formula for sepsis-induced myocardial dysfunction is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dongzhimen Hospital, Beijing | Conditions: Sepsis Induced Myocardial Dysfunction | Phase 2 | Status: RECRUITING